198 related articles for article (PubMed ID: 16000167)
1. Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer.
Abacioglu U; Yumuk PF; Caglar H; Sengoz M; Turhal NS
BMC Cancer; 2005 Jul; 5():71. PubMed ID: 16000167
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
Zwitter M; Kovac V; Smrdel U; Strojan P
J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
[TBL] [Abstract][Full Text] [Related]
3. Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer.
Zinner RG; Komaki R; Cox JD; Glisson BS; Pisters KM; Herbst RS; Kies M; Liao Z; Hong WK; Fossella FV
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):119-27. PubMed ID: 18556142
[TBL] [Abstract][Full Text] [Related]
4. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
[TBL] [Abstract][Full Text] [Related]
5. Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer.
Kerner GS; van Dullemen LF; Wiegman EM; Widder J; Blokzijl E; Driever EM; van Putten JW; Liesker JJ; Renkema TE; Pieterman RM; Mertens MJ; Hiltermann TJ; Groen HJ
Radiat Oncol; 2014 Aug; 9():190. PubMed ID: 25174943
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
Kosmidis P; Fountzilas G; Baka S; Samantas E; Dimopoulos AM; Gogas H; Skarlos D; Papacostas P; Boukovinas J; Bakogiannis Ch; Pantelakos P; Athanasiou H; Misailidou D; Tsekeris P; Pavlidis N
Anticancer Res; 2007; 27(6C):4391-5. PubMed ID: 18214050
[TBL] [Abstract][Full Text] [Related]
7. High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin.
Arrieta O; Gallardo-Rincón D; Villarreal-Garza C; Michel RM; Astorga-Ramos AM; Martínez-Barrera L; de la Garza J
J Thorac Oncol; 2009 Jul; 4(7):845-52. PubMed ID: 19487963
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
Lee DH; Han JY; Cho KH; Pyo HR; Kim HY; Yoon SJ; Lee JS
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1037-44. PubMed ID: 16024178
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
Reboul FL
Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
[TBL] [Abstract][Full Text] [Related]
10. Multimodality treatment of unresectable stage III non-small cell lung cancer: interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy.
Galetta D; Cesario A; Margaritora S; Porziella V; Piraino A; D'Angelillo RM; Gambacorta MA; Ramella S; Trodella L; Valente S; Corbo GM; Macis G; Mulè A; Cardaci V; Sterzi S; Granone P; Russo P
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):314-21. PubMed ID: 16434259
[TBL] [Abstract][Full Text] [Related]
11. Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC).
Garrido P; Engel-Riedel W; Serke M; Giraud P; Ricardi U; Vallejo C; Visseren-Grul C; Ameryckx S; Soldatenkova V; Chouaki N; Novello S
Lung Cancer; 2015 May; 88(2):160-6. PubMed ID: 25758556
[TBL] [Abstract][Full Text] [Related]
12. A Phase I study of gemcitabine with concurrent radiotherapy in stage III, locally advanced non-small cell lung cancer.
van Putten JW; Price A; van der Leest AH; Gregor A; Little FA; Groen HJ
Clin Cancer Res; 2003 Jul; 9(7):2472-7. PubMed ID: 12855620
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
Gagel B; Piroth M; Pinkawa M; Reinartz P; Zimny M; Fischedik K; Stanzel S; Breuer C; Skobel E; Asadpour B; Schmachtenberg A; Buell U; Eble MJ
Strahlenther Onkol; 2006 May; 182(5):263-9. PubMed ID: 16673059
[TBL] [Abstract][Full Text] [Related]
14. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
Wang WH; Bao Y; Chen M; Zhang L; Li KX; Xu GC; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2006 Oct; 25(10):1279-83. PubMed ID: 17059776
[TBL] [Abstract][Full Text] [Related]
15. Incidental surgical findings of a phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer.
Cesario A; Margaritora S; Trodella L; Valente S; Corbo GM; Macis G; Galetta D; d'Angelillo RM; Porziella V; Ramella S; Mangiacotti MG; Granone P
Lung Cancer; 2002 Aug; 37(2):207-12. PubMed ID: 12140144
[TBL] [Abstract][Full Text] [Related]
16. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
17. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
[TBL] [Abstract][Full Text] [Related]
18. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
Hirsh V; Soulieres D; Duclos M; Faria S; Del Vecchio P; Ofiara L; Ayoub JP; Charpentier D; Gruber J; Portelance L; Souhami L
J Thorac Oncol; 2007 Oct; 2(10):927-32. PubMed ID: 17909355
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.
Socinski MA; Blackstock AW; Bogart JA; Wang X; Munley M; Rosenman J; Gu L; Masters GA; Ungaro P; Sleeper A; Green M; Miller AA; Vokes EE
J Clin Oncol; 2008 May; 26(15):2457-63. PubMed ID: 18487565
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of gemcitabine with concurrent radiotherapy on stage III,inoperable non-small cell lung cancer].
Li GZ; Zhang SH; Zhang Z; Wang RL
Ai Zheng; 2007 Dec; 26(12):1377-80. PubMed ID: 18076806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]